1. Identification of genes differentially expressed in association with acquired cisplatin resistance.
- Author
-
Johnsson, A., Zeelenberg, I., Min, Y., Hilinski, J., Berry, C., Howell, S.B., and Los, G.
- Subjects
CISPLATIN ,NUCLEIC acid hybridization ,HIGH throughput screening (Drug development) ,GENE expression ,CELLS ,COMPARATIVE studies ,DRUG resistance in cancer cells ,GENES ,HEAD tumors ,RESEARCH methodology ,MEDICAL cooperation ,NECK tumors ,POLYMERASE chain reaction ,RESEARCH ,RNA ,EVALUATION research ,CANCER cell culture - Abstract
The goal of this study was to identify genes whose mRNA levels are differentially expressed in human cells with acquired cisplatin (cDDP) resistance. Using the parental UMSCC10b head and neck carcinoma cell line and the 5.9-fold cDDP-resistant subline, UMSCC10b/Pt-S15, two suppressive subtraction hybridization (SSH) cDNA libraries were prepared. One library represented mRNAs whose levels were increased in the cDDP resistant variant (the UP library), the other one represented mRNAs whose levels were decreased in the resistant cells (the DOWN library). Arrays constructed with inserts recovered from these libraries were hybridized with SSH products to identify truly differentially expressed elements. A total of 51 cDNA fragments present in the UP library and 16 in the DOWN library met the criteria established for differential expression. The sequences of 87% of these cDNA fragments were identified in Genbank. Among the mRNAs in the UP library that were frequently isolated and that showed high levels of differential expression were cytochrome oxidase I, ribosomal protein 28S, elongation factor 1alpha, alpha-enolase, stathmin, and HSP70. The approach taken in this study permitted identification of many genes never before linked to the cDDP-resistant phenotype. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF